Search tips
Search criteria 


Logo of jexpmedHomeEditorsContactInstructions for Authors
J Exp Med. 1985 January 1; 161(1): 72–87.
PMCID: PMC2187548

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease


Organ-specific autoimmune diseases such as oophoritis, gastritis, thyroiditis, and orchitis were induced in female or male nude (nu/nu) mice by the transfer of nu/+spleen cells from which particular Lyt T cell subset(s) had been removed: nu/+spleen cells treated with anti-Lyt- 1 plus complement (C) caused disease in recipient nude mice; anti-Lyt-2 plus C-treated spleen cells, in contrast, did not. The cells responsible for disease induction are believed to be Thy-1+, Lyt-1-, 2,3- (Thy-1, Lyt-1, 2,3), since spleen cells treated with mixed antisera, including anti-Lyt-1 and anti-Lyt-2, plus C, could induce the disease with almost the same incidence as anti-Lyt-1 plus C-treated cells (oophoritis 50%, gastritis 25%, thyroiditis 10-20%, and orchitis 40%). Cells treated with mixed antisera of anti-Thy-1, anti-Lyt-1, and anti-Lyt-2, plus C, could not induce autoimmune disease. Each induced autoimmune disease could be adoptively transferred to other nude mice via spleen cells, with resulting histological lesion of corresponding organs and development of specific circulating autoantibodies. Since anti-Thy-1 plus C treatment of donor spleen cells abrogated the capacity to transfer the disease, we conclude that T cells are required as effector cells, and that these may develop from Lyt-1-, 2,3- cells. Lyt-1+, 2,3- cells were demonstrated to have suppressive activity upon the development of the diseases; induction of autoimmunity was completely inhibited by the cotransfer of Lyt-1+, 2,3- cells with Lyt-1- , 2,3- cells. When anti-Lyt-2 plus C-treated cells (i.e., Lyt-1+, 2,3- and Lyt-1-, 2,3- cells) were mixed with anti-Lyt-1 and anti-Lyt-2 plus C-treated cells (i.e., Lyt-1-, 2,3- cells) in various ratios, then transferred to nude mice, the development of each autoimmune disease was clearly inhibited, even by small doses of Lyt-1+, 2,3- cells. The autoimmune disease we were able to induce was quite similar to human organ-specific autoimmune disease in terms of the spectrum of organs involved, histopathological features, and the development of autoantibodies to corresponding organ components (oocytes, parietal cells, thyroid colloid, including thyroglobulin, and sperm).(ABSTRACT TRUNCATED AT 400 WORDS)

Full Text

The Full Text of this article is available as a PDF (2.4M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fudenberg HH. Genetically determined immune deficiency as the predisposing cause of "autoimmunity" and lymphoid neoplasia. Am J Med. 1971 Sep;51(3):295–298. [PubMed]
  • Bannister R. Degeneration of the autonomic nervous system. Lancet. 1971 Jul 24;2(7717):175–179. [PubMed]
  • Cunningham AJ. Active suppressor mechanism maintaining tolerance to some self components. Nature. 1975 Mar 13;254(5496):143–144. [PubMed]
  • Kojima A, Prehn RT. Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics. 1981;14(1-2):15–27. [PubMed]
  • Penhale WJ, Farmer A, McKenna RP, Irvine WJ. Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp Immunol. 1973 Oct;15(2):225–236. [PubMed]
  • Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982 Dec 1;156(6):1577–1586. [PMC free article] [PubMed]
  • Penhale WJ, Irvine WJ, Inglis JR, Farmer A. Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitution with normal lymphoid cells. Clin Exp Immunol. 1976 Jul;25(1):6–16. [PubMed]
  • Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med. 1982 Dec 1;156(6):1565–1576. [PMC free article] [PubMed]
  • Nakayama E, Dippold W, Shiku H, Oettgen HF, Old LJ. Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. Proc Natl Acad Sci U S A. 1980 May;77(5):2890–2894. [PubMed]
  • Jenkinson EJ, Van Ewijk W, Owen JJ. Major histocompatibility complex antigen expression on the epithelium of the developing thymus in normal and nude mice. J Exp Med. 1981 Feb 1;153(2):280–292. [PMC free article] [PubMed]
  • Morse HC, 3rd, Steinberg AD, Schur PH, Reed ND. Spontaneous "autoimmune disease" in nude mice. J Immunol. 1974 Aug;113(2):688–697. [PubMed]
  • Ledbetter JA, Rouse RV, Micklem HS, Herzenberg LA. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med. 1980 Aug 1;152(2):280–295. [PMC free article] [PubMed]
  • Manohar V, Brown E, Leiserson WM, Chused TM. Expression of Lyt-1 by a subset of B lymphocytes. J Immunol. 1982 Aug;129(2):532–538. [PubMed]
  • Shiku H, Kisielow P, Bean MA, Takahashi T, Boyse EA, Oettgen HF, Old LJ. Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med. 1975 Jan 1;141(1):227–241. [PMC free article] [PubMed]
  • Kisielow P, Hirst JA, Shiku H, Beverley PC, Hoffman MK, Boyse EA, Oettgen HF. Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature. 1975 Jan 17;253(5488):219–220. [PubMed]
  • Alter BJ, Bach FH. Lyt phenotypes of responding cells in secondary alloantigen responses. J Immunol. 1979 Dec;123(6):2599–2601. [PubMed]
  • Vatteroni ML, Papiernik M. Thymic lymphocytes. II. Phenotypic modifications of thymocytes after concanavalin A stimulation in the presence of interleukin 2: early modifications of Lyt 1+2+ subset and later proliferation of cells with more mature phenotypes. Cell Immunol. 1984 Jan;83(1):124–135. [PubMed]
  • Ihle JN, Rebar L, Keller J, Lee JC, Hapel AJ. Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev. 1982;63:5–32. [PubMed]
  • Theofilopoulos AN, Eisenberg RA, Bourdon M, Crowell JS, Jr, Dixon FJ. Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med. 1979 Feb 1;149(2):516–534. [PMC free article] [PubMed]
  • Creemers P, Giraldo AA, Rose NR, Kong YM. T-cell subsets in the thyroids of mice developing autoimmune thyroiditis. Cell Immunol. 1984 Sep;87(2):692–697. [PubMed]
  • Maron R, Zerubavel R, Friedman A, Cohen IR. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol. 1983 Nov;131(5):2316–2322. [PubMed]
  • Vadas MA, Miller JF, McKenzie IF, Chism SE, Shen FW, Boyse EA, Gamble JR, Whitelaw AM. Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med. 1976 Jul 1;144(1):10–19. [PMC free article] [PubMed]
  • Watanabe N, Kojima S, Shen FW, Ovary Z. Suppression of IgE antibody production in SJL mice. II. Expression of Ly-1 antigen on helper and nonspecific suppressor T cells. J Immunol. 1977 Feb;118(2):485–488. [PubMed]
  • Parish CR. Appearance of non-specific suppressor T cells during in vitro culture. Immunology. 1977 Oct;33(4):597–603. [PubMed]
  • Cantor H, Gershon RK. Immunological circuits: cellular composition. Fed Proc. 1979 Jun;38(7):2058–2064. [PubMed]
  • Benacerraf B, Greene MI, Sy MS, Dorf ME. Suppressor T cell circuits. Ann N Y Acad Sci. 1982;392:300–308. [PubMed]
  • Esquivel PS, Rose NR, Kong YC. Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med. 1977 May 1;145(5):1250–1263. [PMC free article] [PubMed]
  • Bankhurst AD, Torrigiani G, Allison AC. Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet. 1973 Feb 3;1(7797):226–230. [PubMed]
  • Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1966 Jul 30;2(7457):264–265. [PubMed]
  • DONIACH D, RO ITT IM, TAYLOR KB. Autoimmune phenomena in pernicious anaemia. Serological overlap with thyroiditis, thyrotoxicosis, and systemic lupus erythematosus. Br Med J. 1963 May 25;1(5342):1374–1379. [PMC free article] [PubMed]
  • Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. [PMC free article] [PubMed]
  • Gleichmann E, Van Elven EH, Van der Veen JP. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol. 1982 Feb;12(2):152–159. [PubMed]
  • Nossal GJ, Pike BL. Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med. 1975 Apr 1;141(4):904–917. [PMC free article] [PubMed]
  • Bretscher P, Cohn M. A theory of self-nonself discrimination. Science. 1970 Sep 11;169(3950):1042–1049. [PubMed]
  • Weigle WO. Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol. 1971 Oct;9(4):437–447. [PubMed]
  • Gershon RK. T cell control of antibody production. Contemp Top Immunobiol. 1974;3:1–40. [PubMed]
  • Cunningham AJ. Self-tolerance maintained by active suppressor mechanisms. Transplant Rev. 1976;31:23–43. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press